Cargando…
Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
As TNF-α is a major factor in the immune defense against herpes zoster (HZ); an increased incidence and severity of HZ cases were suspected in patients undergoing treatment with TNF antagonists. Several studies and clinical experience provided evidence that the incidence of HZ increases by twofold t...
Autores principales: | el Hayderi, Lara, Colson, Fany, Dezfoulian, Bita, Nikkels, Arjen F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683123/ https://www.ncbi.nlm.nih.gov/pubmed/29387601 http://dx.doi.org/10.2147/PTT.S102202 |
Ejemplares similares
-
Localized Eruptive Blue Nevi after Herpes Zoster
por: Colson, Fany, et al.
Publicado: (2016) -
Hair Loss after Varicella Zoster Virus Infection
por: Hayderi, Lara El, et al.
Publicado: (2013) -
Necrobiosis Lipoidica following Breast Reduction
por: Absil, Gilles, et al.
Publicado: (2021) -
Psoriasis en gotas vs. herpes zóster
por: Trondina, Dinara, et al.
Publicado: (2020) -
Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)